A North Carolina legislative committee has removed from a liability lawsuit measure a provision that would have given broad product protections for pharmaceutical companies.
A Senate judiciary panel has deleted language from the House version that would give drug companies immunity from lawsuits that attacked the safety and quality of their product if the Food and Drug Administration approved the drug for sale.
Committee chairman Sen. Pete Brunstetter of Forsyth County said that lawmakers will now study the issue. He said senators of both parties have raised concerns about the drug provision late in this year’s session.
Attorney General Roy Cooper has warned such a liability restriction would make it more difficult his office to take actions against drug companies that could result in monetary payments for the state.
Topics Politics North Carolina
Was this article valuable?
Here are more articles you may enjoy.
When the Meter Says Wet but the Ceiling Is Dry: A Guide for Adjusters and Inspectors 
Allstate Q3 Net Income Drops About 45% on Higher Catastrophe Losses 
New Florida Property-Tax Cut May Bring an Unwanted Side Effect 
More Florida Insurers Announce Rate Cuts for Auto, Homeowners, Condo Units 
